Live feed
Filing
SC 13D/A
SC 13D/A0001104659-18-053210·Rein Therapeutics, Inc.
Schedule 13D ownership disclosure
AILERON THERAPEUTICS INC
Security class unavailable · CUSIP: 00887A105
Event date: 2018-08-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,396,882
- Percent of class
- 16.2600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-18-053210
- Form type
- SC 13D/A
- Filer
- Rein Therapeutics, Inc.
- CIK
- CIK 1420565
- Filed
- Aug 22, 2018
- Reporting period
- Aug 20, 2018
- Description
- Schedule 13D beneficial ownership